Localized Renal Cell Carcinoma

Radiation for Localized Renal Cell Carcinoma
Kidney cancer is the third most commonly diagnosed genitourinary malignancy in the United States, and it is estimated that the disease will cause nearly 14,000 cancer-related mortalities in 2022.1,2 Most of these patients will have renal cell carcinoma (RCC), primarily with either clear cell (80%-85%) or non–clear cell histology (papillary, chromophobe, oncocytoma).3 Surgery via radical or partial nephrectomy remains the primary treatment modality for patients with localized RCC; however, up to 40% of these patients will ultimately develop metastatic disease even after treatment. ...
Advertisement

Latest News

Advertisement

Knowledge Hub Spotlight

Curated clinical content based on conditions, therapies, and technologies

Phenotypic Precision Medicine in Advanced Prostate Cancer
Phenotypic Precision Medicine in Advanced Prostate Cancer

Conference Coverage

Advertisement
Advertisement
Trending